Pages with the fewest revisions

Showing below up to 50 results in range #1 to #50.

1. Red cell aplasia (1 revision)
2. CR:DOI:6a4dfc88ae05caf8c933038226abf93f (1 revision)
3. CR:DOI:02ebac30bd4090e729efc4a882b6c93d (1 revision)
4. Myelodysplastic disorders (1 revision)
5. Staphylococcus auricularis (1 revision)
6. Property:Incubation period range (1 revision)
7. IgG subclass deficiency (1 revision)
8. Infective endocarditis caused by non-HACEK Gram-negative bacilli (1 revision)
9. CR:DOI:93a20281efae8df25b04c217a2b9e759 (1 revision)
10. Regular narrow-complex tachycardia (1 revision)
11. CR:DOI:fa5d39fcf5033e393d73c851728bc1c4 (1 revision)
12. CR:DOI:d14017def84fc22da503fdd490bb0b3a (1 revision)
13. CR:DOI:ec93673ea6f20fbaf5e479b7e1846f1b (1 revision)
14. Certolizumab pegol (1 revision)
15. Micrococcaceae (1 revision)
16. Model for end-stage liver disease (1 revision)
17. CR:DOI:f4828257713983f4f218bf13c82aa992 (1 revision)
18. Headache with neurological deficits and cerebrospinal fluid lymphocytosis (1 revision)
19. Coagulase-positive staphylococci (1 revision)
20. Blood-borne infections (1 revision)
21. CR:DOI:e05c1b1bd95a37178e2f082567f7fc3d (1 revision)
22. CR:DOI:7969fde7934d219f61cfb5b37b270589 (1 revision)
23. Felty syndrome (1 revision)
24. CR:DOI:484c0725a5f4bd4d826b3f1321b5686d (1 revision)
25. Togaviridae (1 revision)
26. Dominant R-wave in aVR (1 revision)
27. Yeasts (1 revision)
28. NIPPV (1 revision)
29. CR:DOI:f02e515a07b7b94afb259db5668e8149 (1 revision)
30. CR:DOI:6c48ddc8484652e83a2a1dfbefec41f2 (1 revision)
31. MS (1 revision)
32. CR:DOI:4eb9cd71fdb59132cfc7c3dba7ad9fb4 (1 revision)
33. CR:DOI:39f9c7a4945833adcc51233b57fedbe4 (1 revision)
34. Saint Anthony’s fire (1 revision)
35. CR:DOI:5833dec2f6a1c81a835d3b7ec30850b1 (1 revision)
36. CR:DOI:c7bda84dee4ef3d0ca83b48aa011dc93 (1 revision)
37. Necrotizing enterocolitis (1 revision)
38. FAST HUGS BID mnemonic (1 revision)
39. Viral meningitis (1 revision)
40. Corynebacterium coyleae (1 revision)
41. CR:DOI:2350e9bfc05aaf81135ddc258b8d61cb (1 revision)
42. Contrast-induced nephropathy (1 revision)
43. Mitral stenosis (1 revision)
44. Lithium toxicity (1 revision)
45. Durvalumab (1 revision)
46. Body surface area (1 revision)
47. CR:DOI:df680efe495c2efc770398200fea5617 (1 revision)
48. Specific antibody deficiency (1 revision)
49. CR:DOI:c448e71faa408336d58ea256f0c2b504 (1 revision)
50. Pituitary adenomas (1 revision)